CD8A and hepatocellular carcinoma: For example, S100A10 activates the cPLA2/5-LOX axis to initiate lipid metabolic reprogramming, elevating LTB4 levels and promoting CD8+ T cell exhaustion in HCC tissues, thereby driving immune escape and enhancing tumor growth and migration[54].